Novo Holdings' 2025 Results: Discover How They Earned €2.8 Billion
For 2025, the total income and investment returns recorded DKK 21 billion, which translates to approximately €2.8 billion. This substantial figure was primaril…
For 2025, the total income and investment returns recorded DKK 21 billion, which translates to approximately €2.8 billion. This substantial figure was primarily composed of DKK 15 billion (€2.0 billion) from dividends received from companies within the Novo Group, supplemented by DKK 5.8 billion (€0.8 billion) in returns generated from Investment Assets Portfolio 1.
Examining Novo Nordisk (NVO) through the Ranked Stocks lens, it holds an RS Score of 66.29, positioning it in the 45.43rd percentile for its country and the 41.01st percentile within its sector. The stock exhibits particular strength in Valuation (94.49), Growth (94.27), and Profitability (95.37), with these section scores comfortably above 80. Conversely, Momentum (13.09) and EPS Revisions (66.00) register as weaker areas, falling below the 80-point mark. Want to discover which stocks rank the highest? Start your free 7-day trial at rankedstocks.com.